Treatment Response Evaluation using (18)F-FDOPA PET in Patients with Recurrent Malignant Glioma on Bevacizumab Therapy

PURPOSE: This study compares the value of 3,4-dihydroxy-6-[(18)F]-fluoro-L-phenylalanine ((18)F-FDOPA) PET and MRI in assessing outcome during antiangiogenic treatment in patients with recurrent high-grade gliomas. EXPERIMENTAL DESIGN: Thirty patients were prospectively studied with (18)F-FDOPA PET...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Schwarzenberg, Johannes, Czernin, Johannes, Cloughesy, Timothy F., Ellingson, Benjamin M., Pope, Whitney B., Grogan, Tristan, Elashoff, David, Geist, Cheri, Silverman, Daniel H S, Phelps, Michael E., Chen, Wei
Formato: Artigo
Idioma:Inglês
Publicado em: 2014
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4079729/
https://ncbi.nlm.nih.gov/pubmed/24687922
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-13-1440
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados